Soru

Zorluk: OrtaMeasures of Disease Frequency

For each of the following public health and research scenarios, select the specific epidemiological metric that is being calculated.

  • The proportion of patients diagnosed with acute fulminant hepatic failure who die from the condition within 30 days of diagnosis.Case fatality rate
  • The proportion of high school students who report having experienced at least one episode of major depression at any time during the 2025 calendar year.Period prevalence
  • The proportion of initially healthy volunteers who develop a mild local reaction over the course of a 7-day observation window following a novel vaccine administration.Cumulative incidence
  • The number of newly diagnosed melanoma cases divided by the total sum of observation years contributed by all participants in a longitudinal cohort.Incidence rate

Cevap

The hepatic failure scenario matches with Case fatality rate; the major depression scenario matches with Period prevalence; the vaccine reaction scenario matches with Cumulative incidence; the melanoma scenario matches with Incidence rate.
Each scenario describes the unique numerator and denominator characteristics of distinct epidemiological measures. The first focuses on disease severity (deaths among the diagnosed), the second on disease burden over a year (period prevalence), the third on risk in a fixed group over time (cumulative incidence), and the fourth on the speed of disease occurrence using person-time (incidence rate).

Adım Adım Çözüm

1
Analyze the hepatic failure scenario.
Identified as case fatality rate.
It calculates deaths specifically among those already diagnosed with the condition, which measures lethality rather than population mortality.
2
Analyze the major depression scenario.
Identified as period prevalence.
It assesses the existence of a condition (both new and existing cases) at any point over a specified continuous timeframe (the calendar year).
3
Analyze the vaccine reaction scenario.
Identified as cumulative incidence.
It measures the proportion of an initially at-risk, disease-free population that develops a new outcome over a fixed block of time.
4
Analyze the melanoma scenario.
Identified as incidence rate.
The denominator explicitly utilizes 'observation years' (person-time), which is the defining characteristic of an incidence rate compared to cumulative incidence.

Anahtar Kavram

Appropriate selection of disease frequency metrics based on numerator constraints (deaths vs. new cases vs. existing cases) and denominator characteristics (fixed population vs. person-time).
Bu soruyu puanla